K. T. Adiyat, ???Complete Transurethral Resection of Bladder Tumor???: Are the Guidelines Being Followed?, Urology, vol.75, issue.2, pp.365-367, 2010.
DOI : 10.1016/j.urology.2009.08.082

M. Rouprêt, Recommandations en onco-urologie 2016-2018 du CCAFU : Tumeurs de la vessie, Progr??s en Urologie, vol.27, pp.67-91, 2016.
DOI : 10.1016/S1166-7087(16)30704-7

M. Babjuk, EAU Guidelines on Non???Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016, European Urology, vol.71, issue.3, pp.447-461, 2017.
DOI : 10.1016/j.eururo.2016.05.041

J. Dobruch, Clinical value of transurethral second resection of bladder tumor: systematic review. -PubMed -NCBI. Available at: https, p.24, 2017.

M. Grimm, Effect of Routine Repeat Transurethral Resection for Superficial Bladder Cancer: A Long-term Observational Study, The Journal of Urology, vol.170, issue.2, pp.433-437, 2003.
DOI : 10.1097/01.ju.0000070437.14275.e0

W. Kim, Value of Immediate Second Resection of the Tumor Bed to Improve the Effectiveness of Transurethral Resection of Bladder Tumor, Journal of Endourology, vol.26, issue.8, pp.1059-1064, 2012.
DOI : 10.1089/end.2011.0576

R. T. Divrik, A. F. Sahin, U. Yildirim, M. Altok, and F. Zorlu, Impact of Routine Second Transurethral Resection on the Long-Term Outcome of Patients with Newly Diagnosed pT1 Urothelial Carcinoma with Respect to Recurrence, Progression Rate, and Disease-Specific Survival: A Prospective Randomised Clinical Trial, European Urology, vol.58, issue.2, pp.185-190, 2010.
DOI : 10.1016/j.eururo.2010.03.007

R. T. Divrik, U. Yildirim, F. Zorlu, and H. Ozen, The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial, The Journal of Urology, vol.175, issue.5, pp.1641-1644, 2006.
DOI : 10.1016/S0022-5347(05)01002-5

J. P. Sfakianos, P. H. Kim, A. A. Hakimi, and H. W. Herr, The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Gu??rin, The Journal of Urology, vol.191, issue.2, pp.341-345, 2014.
DOI : 10.1016/j.juro.2013.08.022

H. W. Herr, THE VALUE OF A SECOND TRANSURETHRAL RESECTION IN EVALUATING PATIENTS WITH BLADDER TUMORS, The Journal of Urology, vol.162, issue.1, pp.74-76, 1999.
DOI : 10.1097/00005392-199907000-00018

B. Planz, The role of urinary cytology for detection of bladder cancer, European Journal of Surgical Oncology (EJSO), vol.31, issue.3, pp.304-308, 2005.
DOI : 10.1016/j.ejso.2004.12.008

B. W. Van-rhijn and M. Burger, Bladder cancer: Low adherence to guidelines in non-muscle-invasive disease, Nature Reviews Urology, vol.117, issue.10, pp.570-571, 2016.
DOI : 10.1002/cncr.26198

A. Torreggiani, Clinical practice and adherence to the diagnosis and treatment of nmibc guidelines: a report of a recognition based clinical cases study, Rivista Urologia, vol.82, issue.1, pp.58-70, 2015.
DOI : 10.5301/uro.5000107

J. A. Witjes, Current clinical practice gaps in the treatment of intermediate-and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus

. Dans-cette-analyse-rétrospective, 167 patients consécutifs avec une lésion vésicale pTa G3 ou pT1 ont été comparés en fonction de la réalisation ou non d'un « 2nd look

. En-analyse-multivariée, la réalisation d'un « 2nd look » de résection trans urétrale de vessie apparait comme le seul facteur prédictif de meilleure survie sans récidive avec un hazard ratio de 0, p.46